BMO Capital Maintains a Hold Rating on Novo Nordisk (NVO)

Novo Nordisk A/S (NYSE:NVO) is 1 of the Most Profitable Large Cap Stocks to Invest successful Now. On March 30, BMO Capital reiterated a Market Perform standing connected Novo Nordisk A/S (NYSE:NVO) with a $45 terms target.

​The steadfast noted that the standing is based connected beardown momentum from the Wegovy pill motorboat and respective different underappreciated maturation drivers. However, BMO besides flagged immoderate method overstatements and industry-wide maturation risks, which led to a Neutral rating.

The steadfast noted the Wegovy pill motorboat to beryllium beardown and successful enactment with expectations. However, the steadfast pointed retired that the script‑growth numbers whitethorn beryllium somewhat inflated due to the fact that IQVIA’s seizure complaint of prescriptions has accrued to astir 60%, up from astir 50% astatine the precise commencement of the launch.

​Moreover, BMO besides highlighted Novo’s caller concern with HIMS and noted the woody to beryllium incrementally affirmative for Novo merchandise uptake. Following the collaboration, HIMS has stopped promoting compounded GLP‑1s and is present aligning with Novo, which helps code immoderate compounding‑related channel‑dilution concerns. You tin work much astir the deal here.

​​Novo Nordisk A/S (NYSE:NVO) is simply a planetary healthcare institution that develops, manufactures, and markets medicines for superior chronic diseases. It is simply a person successful diabetes attraction (including insulin and Ozempic), obesity absorption (Wegovy), haemophilia care, and uncommon endocrine disorders.

While we admit the imaginable of NVO arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: 33 Stocks That Should Double successful 3 Years and 15 Stocks That Will Make You Rich successful 10 Years. 

Disclosure: None. Follow Insider Monkey connected Google News.